Loading companies…
Loading companies…
Netherlands · Biotech · Healthtech · Enterprise software
Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | €40M | ClavystBio — Role not disclosedEuropean Innovation Council (EIC) Fund — Role not disclosedGates Foundation — Role not disclosedInvest-NL — Role not disclosed |